CoChat

Eph receptors and ephrins as targets for cancer therapy

Open access
Xi, Hong‐Qing, Wu, Xiao‐Song, Wei, Bo, Chen, Lin · 2012 · Journal of Cellular and Molecular Medicine
Cited by 131

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

Eph receptor tyrosine kinases and their ephrin ligands are involved in various signalling pathways and mediate critical steps of a wide variety of physiological and pathological processes. Increasing experimental evidence demonstrates that both Eph receptor and ephrin ligands are overexpressed in a number of human tumours, and are associated with tumour growth, invasiveness and metastasis. In this regard, the Eph/ephrin system provides the foundation for potentially exciting new targets for anticancer therapies for Eph‐expressing tumours. The purpose of this review is to outline current advances in the role of Eph receptors and ephrin ligands in cancer, and to discuss novel therapeutic approaches of anticancer therapies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1582-4934.2012.01612.x

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Research works printed but not linked: 206

  1. 10.1038/35058515 · DOI · Paper page
  2. 10.1016/S1357-2725(02)00096-1 · DOI · Paper page
  3. 10.1002/jcb.21926 · DOI
  4. 10.1016/S0092-8674(00)80500-0 · DOI · Paper page
  5. 10.1126/science.2825356 · DOI · Paper page
  6. 10.1038/368558a0 · DOI · Paper page
  7. 10.1002/j.1460-2075.1994.tb06685.x · DOI
  8. 10.1101/gad.1093703 · DOI · Paper page
  9. 10.1038/modpathol.3800660 · DOI
  10. 10.1002/(SICI)1097-0215(19991022)84:5<494::AID-IJC8>3.0.CO;2-O · DOI
  11. Vogt T, 1998, Overexpression of Lerk‐5/Eplg5 messenger RNA: a novel marker for increased tumorigenicity and metastatic potential in human malignant melanomas, Clin Cancer Res, 4, 791
  12. 10.1073/pnas.190123297 · doi:10.1073/pnas.190123297
  13. 10.1158/1535-7163.MCT-07-0200 · DOI
  14. 10.1593/neo.05277 · doi:10.1593/neo.05277
  15. 10.1038/sj.bjc.6604676 · DOI · Paper page
  16. Zelinski DP, 2001, EphA2 overexpression causes tumorigenesis of mammary epithelial cells, Cancer Res, 61, 2301
  17. 10.1016/j.bbrc.2004.04.102 · DOI · Paper page
  18. Berclaz G, 2002, Loss of EphB4 receptor tyrosine kinase protein expression during carcinogenesis of the human breast, Oncol Rep, 9, 985
  19. 10.1373/clinchem.2003.026849 · DOI · Paper page
  20. 10.1038/nature03626 · DOI · Paper page
  21. 10.1002/ijc.23890 · doi:10.1002/ijc.23890
  22. 10.1002/(SICI)1097-0045(19991201)41:4<275::AID-PROS8>3.0.CO;2-T · DOI · Paper page
  23. Kinch MS, 2003, Predictive value of the EphA2 receptor tyrosine kinase in lung cancer recurrence and survival, Clin Cancer Res, 9, 613
  24. 10.1111/j.1349-7006.2005.00007.x · doi:10.1111/j.1349-7006.2005.00007.x
  25. 10.1007/s00432-002-0355-0 · doi:10.1007/s00432-002-0355-0
  26. 10.1517/14728222.9.6.1179 · DOI · Paper page
  27. 10.1186/1471-2407-6-144 · DOI
  28. 10.1002/ijc.10860 · DOI · Paper page
  29. 10.4149/neo_2009_04_331 · doi:10.4149/neo_2009_04_331
  30. 10.1136/gut.2004.049486 · DOI
  31. 10.12659/MSM.881929 · doi:10.12659/msm.881929
  32. Kiyokawa E, 1994, Overexpression of ERK, an EPH family receptor protein tyrosine kinase, in various human tumors, Cancer Res, 54, 3645
  33. 10.1016/S0896-6273(00)80706-0 · DOI · Paper page
  34. 10.1016/S0896-6273(00)80663-7 · DOI · Paper page
  35. 10.1038/nrm856 · DOI · Paper page
  36. 10.1038/nn1237 · DOI · Paper page
  37. 10.1016/S0896-6273(00)80276-7 · DOI · Paper page
  38. 10.1021/bi991628t · DOI
  39. 10.1016/j.tcb.2007.03.004 · DOI · Paper page
  40. 10.1016/j.neures.2003.11.009 · doi:10.1016/j.neures.2003.11.009
  41. 10.1038/nn1655 · DOI · Paper page
  42. 10.1016/S0166-2236(02)00005-X · DOI · Paper page
  43. 10.1126/stke.2001.112.re20 · doi:10.1126/stke.2001.112.re20
  44. 10.1074/jbc.M500010200 · DOI
  45. 10.1038/sj.onc.1208584 · doi:10.1038/sj.onc.1208584
  46. 10.1128/MCB.21.14.4579-4597.2001 · doi:10.1128/mcb.21.14.4579-4597.2001
  47. 10.1042/BJ20090014 · DOI
  48. 10.1038/nrm1662 · DOI · Paper page
  49. 10.1038/35000008 · DOI · Paper page
  50. 10.1074/jbc.M313356200 · DOI
  51. 10.1016/0092-8674(95)90370-4 · DOI · Paper page
  52. 10.1016/S0092-8674(01)00314-2 · DOI · Paper page
  53. Lawrenson ID, 2002, Ephrin‐A5 induces rounding, blebbing and de‐adhesion of EphA3‐expressing 293T and melanoma cells by CrkII and Rho‐mediated signalling, J Cell Sci, 115, 1059, 10.1242/jcs.115.5.1059 · DOI · Paper page
  54. 10.1038/nn964 · DOI · Paper page
  55. 10.1073/pnas.96.24.13813 · DOI · Paper page
  56. 10.1038/35074604 · DOI · Paper page
  57. 10.1038/35065000 · DOI · Paper page
  58. 10.1126/science.1072682 · DOI · Paper page
  59. 10.1128/MCB.21.21.7429-7441.2001 · DOI · Paper page
  60. 10.1038/sj.onc.1205758 · DOI
  61. 10.1038/sj.onc.1203304 · DOI
  62. 10.1074/jbc.M208972200 · DOI
  63. 10.1016/j.cell.2009.08.048 · DOI · Paper page
  64. 10.1016/j.cell.2006.04.030 · DOI · Paper page
  65. 10.1038/ncb1438 · DOI · Paper page
  66. 10.1126/science.275.5306.1640 · DOI · Paper page
  67. 10.1101/gad.13.23.3125 · DOI · Paper page
  68. 10.1016/j.cell.2012.01.024 · DOI · Paper page
  69. 10.1091/mbc.12.3.685 · DOI · Paper page
  70. 10.1126/science.1719635 · DOI · Paper page
  71. 10.1074/jbc.273.39.25279 · DOI
  72. 10.1074/jbc.M008127200 · DOI · Paper page
  73. 10.1093/emboj/19.20.5396 · DOI · Paper page
  74. 10.1038/383722a0 · DOI · Paper page
  75. 10.1101/gad.1630408 · DOI · Paper page
  76. 10.1038/35093123 · DOI · Paper page
  77. 10.1016/S0092-8674(01)00297-5 · DOI · Paper page
  78. 10.1038/20452 · DOI · Paper page
  79. 10.1016/S0092-8674(01)00191-X · DOI · Paper page
  80. 10.1242/jcs.115.15.3073 · DOI · Paper page
  81. 10.1016/0092-8674(95)90421-2 · DOI · Paper page
  82. 10.1016/0896-6273(95)90335-6 · DOI · Paper page
  83. 10.1016/S0896-6273(00)81240-4 · DOI · Paper page
  84. 10.1016/S0092-8674(00)00197-5 · DOI · Paper page
  85. 10.1016/S0896-6273(01)00440-8 · DOI · Paper page
  86. 10.1016/S0092-8674(02)01015-2 · DOI · Paper page
  87. 10.1093/emboj/18.19.5159 · DOI
  88. 10.1002/ijc.25147 · DOI · Paper page
  89. 10.1006/scdb.2001.0289 · DOI
  90. 10.1242/jcs.02777 · DOI
  91. 10.1038/35058582 · DOI
  92. 10.2174/1381612043383160 · DOI
  93. 10.1016/S0002-9440(10)63899-0 · DOI
  94. 10.1096/fj.05-4038fje · DOI
  95. 10.1038/sj.onc.1208937 · DOI
  96. 10.1172/JCI33154 · DOI · Paper page
  97. 10.1158/1541-7786.MCR-06-0321 · DOI
  98. 10.1074/jbc.M111.329466 · DOI
  99. 10.2353/ajpath.2006.050889 · DOI · Paper page
  100. 10.1371/journal.pone.0024426 · DOI
  101. 10.1038/sj.bjc.6604970 · DOI
  102. 10.1016/S0304-3835(01)00613-9 · DOI
  103. 10.1136/jcp.2010.087213 · DOI
  104. 10.1093/carcin/bgi259 · DOI · Paper page
  105. 10.1158/1078-0432.CCR-05-0143 · DOI
  106. Oshima T, 2008, Overexpression of EphA4 gene and reduced expression of EphB2 gene correlates with liver metastasis in colorectal cancer, Int J Oncol, 33, 573
  107. 10.1093/carcin/bgp133 · DOI
  108. 10.1002/cncr.10122 · DOI · Paper page
  109. 10.1186/1471-2199-2-15 · doi:10.1186/1471-2199-2-15
  110. 10.1038/ncb2122 · DOI · Paper page
  111. 10.1146/annurev.neuro.21.1.309 · DOI · Paper page
  112. 10.1242/dev.126.10.2033 · DOI · Paper page
  113. 10.1016/j.brainresrev.2005.02.001 · DOI
  114. 10.1158/1541-7786.MCR-05-0056 · DOI · Paper page
  115. 10.1158/1535-7163.MCT-07-2263 · DOI
  116. 10.1186/1471-2407-8-79 · DOI
  117. 10.1038/nature03651 · DOI · Paper page
  118. 10.1158/0008-5472.CAN-03-3667 · DOI · Paper page
  119. 10.1158/0008-5472.CAN-05-4211 · DOI
  120. 10.1023/A:1022546620495 · DOI
  121. 10.1038/sj.onc.1206447 · DOI · Paper page
  122. 10.4161/cbt.5.2.2510 · doi:10.4161/cbt.5.2.2510
  123. 10.1038/onc.2011.210 · DOI · Paper page
  124. 10.1002/ijc.2910600119 · doi:10.1002/ijc.2910600119
  125. 10.1074/jbc.M109.075085 · DOI
  126. 10.1158/0008-5472.CAN-10-0717 · DOI
  127. 10.1038/ncomms1675 · DOI
  128. 10.1002/hep.20878 · DOI · Paper page
  129. Wang J, 2010, Expression of EphA1 in gastric carcinomas is associated with metastasis and survival, Oncol Rep, 24, 1577
  130. 10.1007/s12253-008-9132-y · DOI
  131. 10.4149/neo_2012_014 · doi:10.4149/neo_2012_014
  132. 10.1007/s00535-012-0549-4 · DOI
  133. 10.1038/sj.onc.1209780 · DOI
  134. 10.1007/s00432-010-0861-4 · DOI
  135. 10.2353/ajpath.2007.070033 · doi:10.2353/ajpath.2007.070033
  136. 10.1016/S0092-8674(00)80108-7 · DOI · Paper page
  137. 10.1055/s-0038-1657610 · DOI · Paper page
  138. 10.1093/jnci/82.1.4 · DOI · Paper page
  139. 10.1038/nrc2806 · DOI · Paper page
  140. 10.1038/sj.onc.1204004 · DOI · Paper page
  141. 10.1038/sj.onc.1205679 · DOI · Paper page
  142. 10.1016/j.biocel.2008.07.019 · DOI
  143. 10.1152/ajplung.90256.2008 · DOI · Paper page
  144. 10.1016/j.oraloncology.2008.01.018 · DOI
  145. 10.1073/pnas.0401381101 · DOI · Paper page
  146. 10.1007/s10456-010-9183-z · DOI
  147. 10.1038/nature08995 · DOI · Paper page
  148. 10.1016/S1476-5586(03)80047-7 · DOI
  149. 10.1158/0008-5472.CAN-3430-2 · DOI · Paper page
  150. 10.2174/1568009053765780 · DOI · Paper page
  151. 10.1158/1541-7786.MCR-08-0244 · DOI · Paper page
  152. 10.1016/j.tcm.2007.03.003 · DOI · Paper page
  153. 10.1182/blood-2008-02-140020 · doi:10.1182/blood-2008-02-140020
  154. 10.1182/blood-2005-04-1655 · DOI · Paper page
  155. 10.1593/neo.03457 · DOI
  156. 10.1158/0008-5472.CAN-03-1047 · DOI · Paper page
  157. 10.1074/jbc.M500363200 · DOI · Paper page
  158. 10.1016/j.mcn.2003.08.006 · DOI
  159. 10.1074/jbc.M804103200 · DOI · Paper page
  160. Coffman KT, 2003, Differential EphA2 epitope display on normal versus malignant cells, Cancer Res, 63, 7907
  161. 10.1093/jnci/djj414 · DOI
  162. 10.4049/jimmunol.181.11.7721 · DOI
  163. 10.1016/j.bmcl.2006.09.050 · doi:10.1016/j.bmcl.2006.09.050
  164. 10.1016/j.bmcl.2008.09.087 · doi:10.1016/j.bmcl.2008.09.087
  165. 10.1016/j.bmcl.2009.05.029 · DOI
  166. 10.1021/jm9009444 · DOI
  167. 10.1016/j.bmcl.2009.09.010 · DOI
  168. 10.2165/00063030-200822010-00007 · DOI
  169. 10.1158/1541-7786.MCR-08-0169 · DOI · Paper page
  170. 10.1038/sj.bjc.6605101 · DOI · Paper page
  171. 10.1038/sj.bjc.6605381 · DOI
  172. 10.1038/sj.onc.1207247 · DOI · Paper page
  173. 10.1186/1476-4598-1-2 · DOI
  174. 10.1016/j.surneu.2008.04.031 · DOI
  175. 10.1158/0008-5472.CAN-05-0530 · DOI · Paper page
  176. 10.4161/cbt.8.11.8523 · DOI
  177. 10.1158/0008-5472.CAN-08-1933 · DOI · Paper page
  178. 10.1093/jnci/djp231 · DOI
  179. 10.1038/nbt832 · DOI · Paper page
  180. 10.1007/s00259-007-0503-5 · DOI
  181. 10.1158/0008-5472.CAN-05-0758 · DOI
  182. 10.1158/0008-5472.CAN-06-2760 · DOI · Paper page
  183. Tatsumi T, 2003, Disease stage variation in CD4+ and CD8+ T‐cell reactivity to the receptor tyrosine kinase EphA2 in patients with renal cell carcinoma, Cancer Res, 63, 4481
  184. Alves PM, 2003, EphA2 as target of anticancer immunotherapy: identification of HLA‐A*0201‐restricted epitopes, Cancer Res, 63, 8476
  185. 10.1002/cncr.22958 · DOI
  186. 10.1111/j.1349-7006.2008.00866.x · doi:10.1111/j.1349-7006.2008.00866.x
  187. Chiari R, 2000, Identification of a tumor‐specific shared antigen derived from an Eph receptor and presented to CD4 T cells on HLA class II molecules, Cancer Res, 60, 4855
  188. 10.1016/j.ccr.2009.04.009 · DOI · Paper page
  189. 10.1038/sj.onc.1210957 · DOI
  190. 10.1158/0008-5472.CAN-08-1845 · DOI · Paper page
  191. 10.1038/nn.2231 · DOI · Paper page
  192. 10.1242/jcs.036467 · DOI · Paper page
  193. 10.1083/jcb.200306033 · DOI · Paper page
  194. 10.1242/jcs.02842 · DOI · Paper page
  195. 10.1002/dvdy.20978 · DOI · Paper page
  196. Pan M, 2005, Overexpression of EphA2 gene in invasive human breast cancer and its association with hormone receptor status [ASCO Annual Meeting Proceedings], J Clin Oncol, 23, 9583, 10.1200/jco.2005.23.16_suppl.9583 · doi:10.1200/jco.2005.23.16_suppl.9583
  197. 10.1007/BF02893405 · DOI
  198. Maru Y, 1990, Overexpression confers an oncogenic potential upon the eph gene, Oncogene, 5, 445
  199. 10.1111/j.1349-7006.2004.tb03194.x · doi:10.1111/j.1349-7006.2004.tb03194.x
  200. 10.1016/j.bbrc.2006.02.099 · DOI

200 of 206 shown

Cited by

See all 131

Metadata

Authors
Xi, H., Wu, X., Wei, B., & Chen, L.
Venue
Journal of Cellular and Molecular Medicine
Publisher
Wiley
Published
2012-12
Volume
16
Issue
12
Pages
2894-2909
ISSN
  • 1582-1838 (ISSN-L)
  • 1582-4934
OpenAlex
W2067487060
Cited by
131
References
2
FWCI
3.60
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Eph receptors and ephrins as targets for cancer therapy. https://app.cochat.ai/papers/10.1111/j.1582-4934.2012.01612.x
The paper
Xi, H., Wu, X., Wei, B., & Chen, L. (2012). Eph receptors and ephrins as targets for cancer therapy. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/j.1582-4934.2012.01612.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.